focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: JD Sports falls after Nike cuts revenue forecast

Fri, 24th Sep 2021 09:02

(Alliance News) - Stock prices in London opened lower on Friday amid growing worries over the UK's economic prospects, while JD Sports fell to the bottom of the FTSE 100 after top brand Nike warned that supply issues will hurt annual revenue.

The FTSE 100 index was down 22.46 points, or 0.3%, at 7,055.89 early Friday. The mid-cap FTSE 250 index was down 94.85 points, or 0.4%, at 23,735.85. The AIM All-Share index was flat at 1,271.98.

The Cboe UK 100 index was down 0.3% at 701.40. The Cboe 250 was down 0.3%, at 21,524.30. The Cboe Small Companies was 0.1% lower at 15,592.80.

In mainland Europe, the CAC 40 stock index in Paris was down 0.5% and the DAX 40 index in Frankfurt was down 0.7%.

Consumer confidence in the UK has plunged amid increasing anxiety about the rising cost of living, a long-running survey suggested.

GfK's Consumer Confidence Barometer fell by five points to minus 13 in September, a drop not seen since October last year. All measures of the survey, including confidence in the general economic situation and personal finances, were down in comparison to last month.

"When consumer confidence drops, shoppers tend to spend less, and this dampens the overall economic prospects for the UK. This really is an unwelcome picture going into 2022 and beyond," said GfK's Joe Staton.

The index also recorded a three-point drop to minus six in the major purchase index, an indicator of consumer confidence in buying big ticket items, in worrying news for hard-pressed retailers looking to build sales as they go into the key holiday period.

"Rising inflation, cuts to government support schemes, the power crisis along with the potential lack of products available are clearly a worry within the UK and likely to be causing big challenges for the Conservative party, especially with its upcoming annual conference. We expect these concerns to remain headwinds to the GfK consumer index recovery, throughout the upcoming months," said analysts at Shore Capital.

In the FTSE 100, AstraZeneca was the best performer, up 3.3%, after the drugmaker announced positive results from the PROpel phase three trial of Lynparza.

The Anglo-Swedish firm said that the PROpel phase three trial for Lynparza achieved its primary endpoint of radiographic progression-free survival in men with metastatic castration-resistant prostate cancer, compared to standard-of-care abiraterone.

Interim analysis by the Independent Data Monitoring Committee concluded that the trial met the primary endpoint in men which had not received treatment in the first-line setting including new hormonal agents or chemotherapy.

At the other end of the large-caps, JD Sports Fashion was the worst performer, down 2.7%, with the sportswear retailer suffering a negative read-across from Nike.

The US athletic apparel maker late Thursday reopened first quarter results which missed consensus estimates. The stock fell 3.9% in after-hours trade in New York.

In the period ended August 31, Nike's revenue climbed 16% annually to USD12.25 billion from USD10.59 billion a year earlier. Quarter-on-quarter, revenue declined 0.8%. The first-quarter top line came in below CNN-cited consensus of USD12.5 billion.

On the subsequent conference call, Nike said sales may fall as factory closures in Vietnam prevent the company from keeping up with consumer demand.

"Several of our factory partners in Vietnam and Indonesia were required to abruptly cease operations in the first quarter. As of today, Indonesia is now fully operational, but in Vietnam, nearly all footwear factories remain closed by government mandate. Our experience with COVID-related factory closures suggest that re-opening and ramping back to full production scale takes time," Nike said.

As such, Nike said full-year revenue will be in the mid-single-digits rather than a low double-digit percentage rate it earlier targeted.

"The problem for Nike is that these problems are not easy to fix and there is no telling when the situation will improve. The CEO of Covid vaccine maker Moderna predicted yesterday that it would take another year for the pandemic to disappear, meaning the current supply bottleneck could last for months," said eToro analyst Mark Crouch.

German sportswear brand Adidas was down 3.3% in Frankfurt.

In the FTSE 250, Mitie Group was up 3.0% after the outsourcer raised its profit guidance due to a series of Covid-linked contract awards.

Mitie said it now expects to deliver operating profit of between GBP145 million and GBP155 million in its financial year ending March 31, 2022. Operating profit before items was GBP63.4 million in financial 2021 and GBP86.1 million in financial 2020.

LondonMetric Property was up 2.0% after Citigroup raised the distribution and long income property investor to Buy from Hold.

The Japanese Nikkei 225 index closed up 2.1% on Friday, reopening after being closed for a holiday on Thursday. In China, the Shanghai Composite closed down 0.8%, while the Hang Seng index in Hong Kong was down 0.1%. The S&P/ASX 200 in Sydney ended down 0.4%.

The pound was quoted at USD.3705 early Friday, down from USD1.3736 at the London equity market close on Thursday.

The euro was priced at USD1.1732, little changed from USD1.1735. Against the Japanese yen, the dollar was trading at JPY110.44, up from JPY110.18.

Brent was quoted at USD77.61 a barrel Friday morning, up sharply from USD75.94 late Thursday. Gold stood at USD1,755.47 an ounce, higher against USD1,748.28.

Friday's economic calendar has Ifo's business climate index for Germany at 0900 BST.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.